Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-098626
Filing Date
2022-09-08
Accepted
2022-09-08 21:33:24
Documents
2
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2225478-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2225478-1_3seq1.xml 3 1624
2 EXHIBIT 24.1 tm2225478d1_ex24-1.htm EX-24.1 8268
  Complete submission text file 0001104659-22-098626.txt   11394
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1 CAMBRIDGE MA 02141
Business Address
Schilsky Richard (Reporting) CIK: 0001945662 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37990 | Film No.: 221234903